My Quote Request
No products added yet
6505-01-098-4518
20 Products
NDC00071-0553-24
PRAZEPAM CAPSULES,USP
NSN, MFG P/N
6505010984518
NSN
6505-01-098-4518
NDC00071-0553-24
PRAZEPAM CAPSULES,USP
NSN, MFG P/N
6505010984518
NSN
6505-01-098-4518
MFG
PARKE-DAVIS DIV OF WARNER-LAMBERT CO
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS PRAZEPAM ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
CENTRAX CAPSULES
PRAZEPAM CAPSULES,USP
NSN, MFG P/N
6505010984518
NSN
6505-01-098-4518
CENTRAX CAPSULES
PRAZEPAM CAPSULES,USP
NSN, MFG P/N
6505010984518
NSN
6505-01-098-4518
MFG
PARKE-DAVIS DIV OF WARNER-LAMBERT CO
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS PRAZEPAM ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00555-0159-02
CHLORDIAZEPOXIDE HYDROCHLORIDE CAPSULES,USP
NSN, MFG P/N
6505010985801
NSN
6505-01-098-5801
NDC00555-0159-02
CHLORDIAZEPOXIDE HYDROCHLORIDE CAPSULES,USP
NSN, MFG P/N
6505010985801
NSN
6505-01-098-5801
MFG
BARR PHARMACEUTICALS LLC
Description
(NON-CORE DATA) EXTERIOR CONTAINER CUBIC MEASURE: 1.693 CUBIC FEET
(NON-CORE DATA) EXTERIOR CONTAINER QUANTITY: 80
(NON-CORE DATA) EXTERIOR CONTAINER WEIGHT: 17.00 POUNDS
(NON-CORE DATA) INTERMEDIATE PACKAGE QUANTITY: 10
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.211 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 0.21 POUNDS
(NON-CORE DATA) UNIT PACKAGE TYPE: PACKAGE
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 25.000 MILLIGRAMS CHLORDIAZEPOXIDE HYDROCHLORIDE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: POWDER
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 25.000
CAPSULE TYPE: HARD
FEATURES PROVIDED: INDIVIDUALLY SEALED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CHLORDIAZEPOXIDE HYDROCHLORIDE CAPSULES USP 25MG I.S. 100S PG
PRIMARY CONTAINER QUANTITY PER SECONDARY CONTAINER: 1 STRIP, ROLL
PRIMARY CONTAINER TYPE: STRIP, ROLL
PROTECTIVE STORAGE FEATURE: SECURITY STORAGE
SECONDARY CONTAINER TYPE: BOX
SPECIAL FEATURES: C/O FOUR BOXES,EACH CONTAINING 25 CAPSULES IN REVERSE-NUMBERED ROLLED STRIP
TOTAL PRIMARY CONTAINER QUANTITY: 4
TOTAL SECONDARY CONTAINER QUANTITY: 4
Related Searches:
NDC51079-0285-21
DIAZEPAM TABLETS,USP
NSN, MFG P/N
6505010985802
NSN
6505-01-098-5802
NDC51079-0285-21
DIAZEPAM TABLETS,USP
NSN, MFG P/N
6505010985802
NSN
6505-01-098-5802
MFG
UDL LABORATORIES INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS DIAZEPAM ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DIAZEPAM TABLETS USP 5MG INDIVIDUALLY SEALED 100S
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: STRIP, ROLL
PROTECTIVE STORAGE FEATURE: SECURITY STORAGE
SPECIAL FEATURES: INDIVIDUALLY SEALED; REVERSE-NUMBERED ROLLED STRIPS
Related Searches:
NDC51079-0286-21
DIAZEPAM TABLETS,USP
NSN, MFG P/N
6505010985803
NSN
6505-01-098-5803
NDC51079-0286-21
DIAZEPAM TABLETS,USP
NSN, MFG P/N
6505010985803
NSN
6505-01-098-5803
MFG
UDL LABORATORIES INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS DIAZEPAM ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: DIAZEPAM TABLETS USP 10MG INDIVIDUALLY SEALED 100S
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: STRIP, ROLL
PROTECTIVE STORAGE FEATURE: SECURITY STORAGE
SPECIAL FEATURES: INDIVIDUALLY SEALED; REVERSE NUMBERED ROLLED STRIPS
Related Searches:
NDC00002-1608-02
SILVER NITRATE OPHTHALMIC SOLUTION,USP
NSN, MFG P/N
6505010986563
NSN
6505-01-098-6563
NDC00002-1608-02
SILVER NITRATE OPHTHALMIC SOLUTION,USP
NSN, MFG P/N
6505010986563
NSN
6505-01-098-6563
MFG
ELI LILLY AND COMPANY DBA ELI LILLY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 PERCENTAGE, W/V SILVER NITRATE ACTIVE INGREDIENT
ADMINISTRATION: TOPICAL
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SILVER NITRATE OPHTHALMIC SOLUTION USP 1% .250ML AMPUL 100S BX
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
III SUPPLEMENTARY FEATURES: ONE AMPULE SUFFICIENT TO TREAT ONE INFANT. FOR PREVENTING EYE INFECTION IN NEWBORN INFANTS
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 0.250 MILLILITERS
PRIMARY CONTAINER TYPE: AMPUL
SPECIAL FEATURES: WAX AMPULS,SODIUM ACETATE BUFFER
TOTAL PRIMARY CONTAINER QUANTITY: 100
Related Searches:
6505-LL-L00-2939
MULTIVITAMIN AND MINERAL TABLETS
NSN, MFG P/N
6505010986872
NSN
6505-01-098-6872
6505-LL-L00-2939
MULTIVITAMIN AND MINERAL TABLETS
NSN, MFG P/N
6505010986872
NSN
6505-01-098-6872
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 20.000 MILLIGRAMS CALCIUM PANTOTHENATE ACTIVE INGREDIENT AND 2.000 MILLIGRAMS COPPER ACTIVE INGREDIENT AND 0.150 MILLIGRAMS IODINE ACTIVE INGREDIENT AND 12.000 MILLIGRAMS IRON ACTIVE INGREDIENT AND 65.000 MILLIGRAMS MAGNESIUM ACTIVE INGREDIENT AND 1.000
ADMINISTRATION: ORAL
FEATURES PROVIDED: INDIVIDUALLY SEALED AND ENTERIC COATED
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: 100 TABLETS
~1: MILLIGRAMS MANGANESE ACTIVE INGREDIENT AND 100.000 MILLIGRAMS NIACINAMIDE ACTIVE INGREDIENT AND 10.000 MILLIGRAMS RIBOFLAVIN ACTIVE INGREDIENT AND 10.000 MILLIGRAMS THIAMINE MONONITRATE ACTIVE INGREDIENT AND 1.500 MILLIGRAMS ZINC ACTIVE INGREDIENT AND
~2: 10000.000 INTERNATIONAL UNITS VITAMIN A ACETATE ACTIVE INGREDIENT AND 5.000 MILLIGRAMS VITAMIN B6 ACTIVE INGREDIENT AND 5.000 MICROGRAMS VITAMIN B12 ACTIVE INGREDIENT AND 200.000 MILLIGRAMS VITAMIN C ACTIVE INGREDIENT AND 400.000 INTERNATIONAL UNITS
~3: VITAMIN D ACTIVE INGREDIENT AND 15.000 INTERNATIONAL UNITS VITAMIN E ACTIVE INGREDIENT
Related Searches:
NDC47679-0135-35
MULTIVITAMIN AND MINERAL TABLETS
NSN, MFG P/N
6505010986872
NSN
6505-01-098-6872
NDC47679-0135-35
MULTIVITAMIN AND MINERAL TABLETS
NSN, MFG P/N
6505010986872
NSN
6505-01-098-6872
MFG
BAXTER HEALTHCARE CORP PHARMACEUTICALS DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 20.000 MILLIGRAMS CALCIUM PANTOTHENATE ACTIVE INGREDIENT AND 2.000 MILLIGRAMS COPPER ACTIVE INGREDIENT AND 0.150 MILLIGRAMS IODINE ACTIVE INGREDIENT AND 12.000 MILLIGRAMS IRON ACTIVE INGREDIENT AND 65.000 MILLIGRAMS MAGNESIUM ACTIVE INGREDIENT AND 1.000
ADMINISTRATION: ORAL
FEATURES PROVIDED: INDIVIDUALLY SEALED AND ENTERIC COATED
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: 100 TABLETS
~1: MILLIGRAMS MANGANESE ACTIVE INGREDIENT AND 100.000 MILLIGRAMS NIACINAMIDE ACTIVE INGREDIENT AND 10.000 MILLIGRAMS RIBOFLAVIN ACTIVE INGREDIENT AND 10.000 MILLIGRAMS THIAMINE MONONITRATE ACTIVE INGREDIENT AND 1.500 MILLIGRAMS ZINC ACTIVE INGREDIENT AND
~2: 10000.000 INTERNATIONAL UNITS VITAMIN A ACETATE ACTIVE INGREDIENT AND 5.000 MILLIGRAMS VITAMIN B6 ACTIVE INGREDIENT AND 5.000 MICROGRAMS VITAMIN B12 ACTIVE INGREDIENT AND 200.000 MILLIGRAMS VITAMIN C ACTIVE INGREDIENT AND 400.000 INTERNATIONAL UNITS
~3: VITAMIN D ACTIVE INGREDIENT AND 15.000 INTERNATIONAL UNITS VITAMIN E ACTIVE INGREDIENT
Related Searches:
FLUORESCITE
FLUORESCEIN INJECTION,USP
NSN, MFG P/N
6505010989623
NSN
6505-01-098-9623
FLUORESCITE
FLUORESCEIN INJECTION,USP
NSN, MFG P/N
6505010989623
NSN
6505-01-098-9623
MFG
ALCON LABORATORIES INC .
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 PERCENTAGE, W/V FLUORESCEIN SODIUM ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: FLUORESCEIN INJECTION USP 5ML AMPUL 12S PG
PRIMARY CONTAINER CONTENT QUANTITY: 5.000 MILLILITERS
PRIMARY CONTAINER TYPE: AMPUL
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
NDC00065-0092-05
FLUORESCEIN INJECTION,USP
NSN, MFG P/N
6505010989623
NSN
6505-01-098-9623
NDC00065-0092-05
FLUORESCEIN INJECTION,USP
NSN, MFG P/N
6505010989623
NSN
6505-01-098-9623
MFG
ALCON LABORATORIES INC .
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 PERCENTAGE, W/V FLUORESCEIN SODIUM ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: FLUORESCEIN INJECTION USP 5ML AMPUL 12S PG
PRIMARY CONTAINER CONTENT QUANTITY: 5.000 MILLILITERS
PRIMARY CONTAINER TYPE: AMPUL
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
260
ERGOLOID MESYLATES TABLETS,USP
NSN, MFG P/N
6505010993250
NSN
6505-01-099-3250
MFG
ARMCO MEDICAL SUPPLY INC DBA US TRADING
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.333 MILLIGRAMS DIHYDROERGOCORNINE MESYLATE ACTIVE INGREDIENT AND 0.333 MILLIGRAMS DIHYDROERGOCRISTINE MESYLATE ACTIVE INGREDIENT AND 0.333 MILLIGRAMS DIHYDROERGOCRYPTINE MESYLATE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: 100 INDIVIDUALLY SEALED TABLETS
Related Searches:
HYDERGINE
ERGOLOID MESYLATES TABLETS,USP
NSN, MFG P/N
6505010993250
NSN
6505-01-099-3250
HYDERGINE
ERGOLOID MESYLATES TABLETS,USP
NSN, MFG P/N
6505010993250
NSN
6505-01-099-3250
MFG
NOVARTIS PHARMACEUTICALS CORPORATION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.333 MILLIGRAMS DIHYDROERGOCORNINE MESYLATE ACTIVE INGREDIENT AND 0.333 MILLIGRAMS DIHYDROERGOCRISTINE MESYLATE ACTIVE INGREDIENT AND 0.333 MILLIGRAMS DIHYDROERGOCRYPTINE MESYLATE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: 100 INDIVIDUALLY SEALED TABLETS
Related Searches:
NDC00078-0070-06
ERGOLOID MESYLATES TABLETS,USP
NSN, MFG P/N
6505010993250
NSN
6505-01-099-3250
NDC00078-0070-06
ERGOLOID MESYLATES TABLETS,USP
NSN, MFG P/N
6505010993250
NSN
6505-01-099-3250
MFG
NOVARTIS PHARMACEUTICALS CORPORATION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.333 MILLIGRAMS DIHYDROERGOCORNINE MESYLATE ACTIVE INGREDIENT AND 0.333 MILLIGRAMS DIHYDROERGOCRISTINE MESYLATE ACTIVE INGREDIENT AND 0.333 MILLIGRAMS DIHYDROERGOCRYPTINE MESYLATE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: 100 INDIVIDUALLY SEALED TABLETS
Related Searches:
NDC00615-1585-13
ERGOLOID MESYLATES TABLETS,USP
NSN, MFG P/N
6505010993250
NSN
6505-01-099-3250
NDC00615-1585-13
ERGOLOID MESYLATES TABLETS,USP
NSN, MFG P/N
6505010993250
NSN
6505-01-099-3250
MFG
MEDICAL TECHNOLOGIES SYSTEM INC VANGARD LABS DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.333 MILLIGRAMS DIHYDROERGOCORNINE MESYLATE ACTIVE INGREDIENT AND 0.333 MILLIGRAMS DIHYDROERGOCRISTINE MESYLATE ACTIVE INGREDIENT AND 0.333 MILLIGRAMS DIHYDROERGOCRYPTINE MESYLATE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: 100 INDIVIDUALLY SEALED TABLETS
Related Searches:
NDC00187-3751-10
CHLORDIAZEPOXIDE HYDROCHLORIDE CAPSULES,USP
NSN, MFG P/N
6505010994064
NSN
6505-01-099-4064
NDC00187-3751-10
CHLORDIAZEPOXIDE HYDROCHLORIDE CAPSULES,USP
NSN, MFG P/N
6505010994064
NSN
6505-01-099-4064
MFG
VALEANT PHARMACEUTICALS INTERNATIONAL
Description
(NON-CORE DATA) EXTERIOR CONTAINER CUBIC MEASURE: 1.693 CUBIC FEET
(NON-CORE DATA) EXTERIOR CONTAINER QUANTITY: 80
(NON-CORE DATA) EXTERIOR CONTAINER WEIGHT: 17.00 POUNDS
(NON-CORE DATA) INTERMEDIATE PACKAGE QUANTITY: 10
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.212 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 0.21 POUNDS
(NON-CORE DATA) UNIT PACKAGE TYPE: PACKAGE
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS CHLORDIAZEPOXIDE HYDROCHLORIDE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: POWDER
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 25.000
CAPSULE TYPE: HARD
FEATURES PROVIDED: INDIVIDUALLY SEALED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CHLORDIAZEPOXIDE HYDROCHLORIDE CAPSULES USP 10MG I.S. 100S
PRIMARY CONTAINER QUANTITY PER SECONDARY CONTAINER: 1 STRIP, ROLL
PRIMARY CONTAINER TYPE: STRIP, ROLL
PROTECTIVE STORAGE FEATURE: SECURITY STORAGE
SECONDARY CONTAINER TYPE: BOX
SPECIAL FEATURES: REVERSE-NUMBERED ROLLED STRIPS
SUPPLEMENTARY FEATURES: CONSISTS OF 4 BOXES EA CONTAINING 25 CAPSULES
TOTAL PRIMARY CONTAINER QUANTITY: 4
TOTAL SECONDARY CONTAINER QUANTITY: 4
Related Searches:
NDC00555-0033-02
CHLORDIAZEPOXIDE HYDROCHLORIDE CAPSULES,USP
NSN, MFG P/N
6505010994064
NSN
6505-01-099-4064
NDC00555-0033-02
CHLORDIAZEPOXIDE HYDROCHLORIDE CAPSULES,USP
NSN, MFG P/N
6505010994064
NSN
6505-01-099-4064
MFG
BARR PHARMACEUTICALS LLC
Description
(NON-CORE DATA) EXTERIOR CONTAINER CUBIC MEASURE: 1.693 CUBIC FEET
(NON-CORE DATA) EXTERIOR CONTAINER QUANTITY: 80
(NON-CORE DATA) EXTERIOR CONTAINER WEIGHT: 17.00 POUNDS
(NON-CORE DATA) INTERMEDIATE PACKAGE QUANTITY: 10
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.212 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 0.21 POUNDS
(NON-CORE DATA) UNIT PACKAGE TYPE: PACKAGE
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS CHLORDIAZEPOXIDE HYDROCHLORIDE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: POWDER
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 25.000
CAPSULE TYPE: HARD
FEATURES PROVIDED: INDIVIDUALLY SEALED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CHLORDIAZEPOXIDE HYDROCHLORIDE CAPSULES USP 10MG I.S. 100S
PRIMARY CONTAINER QUANTITY PER SECONDARY CONTAINER: 1 STRIP, ROLL
PRIMARY CONTAINER TYPE: STRIP, ROLL
PROTECTIVE STORAGE FEATURE: SECURITY STORAGE
SECONDARY CONTAINER TYPE: BOX
SPECIAL FEATURES: REVERSE-NUMBERED ROLLED STRIPS
SUPPLEMENTARY FEATURES: CONSISTS OF 4 BOXES EA CONTAINING 25 CAPSULES
TOTAL PRIMARY CONTAINER QUANTITY: 4
TOTAL SECONDARY CONTAINER QUANTITY: 4
Related Searches:
NDC00591-0786-01
CHLORDIAZEPOXIDE HYDROCHLORIDE CAPSULES,USP
NSN, MFG P/N
6505010994064
NSN
6505-01-099-4064
NDC00591-0786-01
CHLORDIAZEPOXIDE HYDROCHLORIDE CAPSULES,USP
NSN, MFG P/N
6505010994064
NSN
6505-01-099-4064
MFG
DANBURY PHARMACAL INC
Description
(NON-CORE DATA) EXTERIOR CONTAINER CUBIC MEASURE: 1.693 CUBIC FEET
(NON-CORE DATA) EXTERIOR CONTAINER QUANTITY: 80
(NON-CORE DATA) EXTERIOR CONTAINER WEIGHT: 17.00 POUNDS
(NON-CORE DATA) INTERMEDIATE PACKAGE QUANTITY: 10
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.212 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 0.21 POUNDS
(NON-CORE DATA) UNIT PACKAGE TYPE: PACKAGE
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS CHLORDIAZEPOXIDE HYDROCHLORIDE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: POWDER
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 25.000
CAPSULE TYPE: HARD
FEATURES PROVIDED: INDIVIDUALLY SEALED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CHLORDIAZEPOXIDE HYDROCHLORIDE CAPSULES USP 10MG I.S. 100S
PRIMARY CONTAINER QUANTITY PER SECONDARY CONTAINER: 1 STRIP, ROLL
PRIMARY CONTAINER TYPE: STRIP, ROLL
PROTECTIVE STORAGE FEATURE: SECURITY STORAGE
SECONDARY CONTAINER TYPE: BOX
SPECIAL FEATURES: REVERSE-NUMBERED ROLLED STRIPS
SUPPLEMENTARY FEATURES: CONSISTS OF 4 BOXES EA CONTAINING 25 CAPSULES
TOTAL PRIMARY CONTAINER QUANTITY: 4
TOTAL SECONDARY CONTAINER QUANTITY: 4
Related Searches:
NDC49884-0959-01
CHLORDIAZEPOXIDE HYDROCHLORIDE CAPSULES,USP
NSN, MFG P/N
6505010994064
NSN
6505-01-099-4064
NDC49884-0959-01
CHLORDIAZEPOXIDE HYDROCHLORIDE CAPSULES,USP
NSN, MFG P/N
6505010994064
NSN
6505-01-099-4064
MFG
PAR PHARMACEUTICAL INC.
Description
(NON-CORE DATA) EXTERIOR CONTAINER CUBIC MEASURE: 1.693 CUBIC FEET
(NON-CORE DATA) EXTERIOR CONTAINER QUANTITY: 80
(NON-CORE DATA) EXTERIOR CONTAINER WEIGHT: 17.00 POUNDS
(NON-CORE DATA) INTERMEDIATE PACKAGE QUANTITY: 10
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.212 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 0.21 POUNDS
(NON-CORE DATA) UNIT PACKAGE TYPE: PACKAGE
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS CHLORDIAZEPOXIDE HYDROCHLORIDE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: POWDER
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 25.000
CAPSULE TYPE: HARD
FEATURES PROVIDED: INDIVIDUALLY SEALED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CHLORDIAZEPOXIDE HYDROCHLORIDE CAPSULES USP 10MG I.S. 100S
PRIMARY CONTAINER QUANTITY PER SECONDARY CONTAINER: 1 STRIP, ROLL
PRIMARY CONTAINER TYPE: STRIP, ROLL
PROTECTIVE STORAGE FEATURE: SECURITY STORAGE
SECONDARY CONTAINER TYPE: BOX
SPECIAL FEATURES: REVERSE-NUMBERED ROLLED STRIPS
SUPPLEMENTARY FEATURES: CONSISTS OF 4 BOXES EA CONTAINING 25 CAPSULES
TOTAL PRIMARY CONTAINER QUANTITY: 4
TOTAL SECONDARY CONTAINER QUANTITY: 4
Related Searches:
NDC51079-0375-20
CHLORDIAZEPOXIDE HYDROCHLORIDE CAPSULES,USP
NSN, MFG P/N
6505010994064
NSN
6505-01-099-4064
NDC51079-0375-20
CHLORDIAZEPOXIDE HYDROCHLORIDE CAPSULES,USP
NSN, MFG P/N
6505010994064
NSN
6505-01-099-4064
MFG
UDL LABORATORIES INC
Description
(NON-CORE DATA) EXTERIOR CONTAINER CUBIC MEASURE: 1.693 CUBIC FEET
(NON-CORE DATA) EXTERIOR CONTAINER QUANTITY: 80
(NON-CORE DATA) EXTERIOR CONTAINER WEIGHT: 17.00 POUNDS
(NON-CORE DATA) INTERMEDIATE PACKAGE QUANTITY: 10
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.212 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 0.21 POUNDS
(NON-CORE DATA) UNIT PACKAGE TYPE: PACKAGE
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS CHLORDIAZEPOXIDE HYDROCHLORIDE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: POWDER
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 25.000
CAPSULE TYPE: HARD
FEATURES PROVIDED: INDIVIDUALLY SEALED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CHLORDIAZEPOXIDE HYDROCHLORIDE CAPSULES USP 10MG I.S. 100S
PRIMARY CONTAINER QUANTITY PER SECONDARY CONTAINER: 1 STRIP, ROLL
PRIMARY CONTAINER TYPE: STRIP, ROLL
PROTECTIVE STORAGE FEATURE: SECURITY STORAGE
SECONDARY CONTAINER TYPE: BOX
SPECIAL FEATURES: REVERSE-NUMBERED ROLLED STRIPS
SUPPLEMENTARY FEATURES: CONSISTS OF 4 BOXES EA CONTAINING 25 CAPSULES
TOTAL PRIMARY CONTAINER QUANTITY: 4
TOTAL SECONDARY CONTAINER QUANTITY: 4
Related Searches:
NDC51079-0375-21
CHLORDIAZEPOXIDE HYDROCHLORIDE CAPSULES,USP
NSN, MFG P/N
6505010994064
NSN
6505-01-099-4064
NDC51079-0375-21
CHLORDIAZEPOXIDE HYDROCHLORIDE CAPSULES,USP
NSN, MFG P/N
6505010994064
NSN
6505-01-099-4064
MFG
UDL LABORATORIES INC
Description
(NON-CORE DATA) EXTERIOR CONTAINER CUBIC MEASURE: 1.693 CUBIC FEET
(NON-CORE DATA) EXTERIOR CONTAINER QUANTITY: 80
(NON-CORE DATA) EXTERIOR CONTAINER WEIGHT: 17.00 POUNDS
(NON-CORE DATA) INTERMEDIATE PACKAGE QUANTITY: 10
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.212 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 0.21 POUNDS
(NON-CORE DATA) UNIT PACKAGE TYPE: PACKAGE
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS CHLORDIAZEPOXIDE HYDROCHLORIDE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: POWDER
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 25.000
CAPSULE TYPE: HARD
FEATURES PROVIDED: INDIVIDUALLY SEALED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CHLORDIAZEPOXIDE HYDROCHLORIDE CAPSULES USP 10MG I.S. 100S
PRIMARY CONTAINER QUANTITY PER SECONDARY CONTAINER: 1 STRIP, ROLL
PRIMARY CONTAINER TYPE: STRIP, ROLL
PROTECTIVE STORAGE FEATURE: SECURITY STORAGE
SECONDARY CONTAINER TYPE: BOX
SPECIAL FEATURES: REVERSE-NUMBERED ROLLED STRIPS
SUPPLEMENTARY FEATURES: CONSISTS OF 4 BOXES EA CONTAINING 25 CAPSULES
TOTAL PRIMARY CONTAINER QUANTITY: 4
TOTAL SECONDARY CONTAINER QUANTITY: 4
